"Fecal transplantation for the treatment of Clostridium difficile-associated disease or ulcerative colitis" examines the clinical research evidence on the safety and effects of fecal transplantation in the treatment of patients with Clostridium difficile-associated disease and/or ulcerative colitis. It also provides information on the prevalence and incidence of the two diseases and the availability of fecal transplantation procedure in Alberta and Canada. The Institute of Health Economics prepared this STE report at the request of the Government of Alberta as part of the Institute's ongoing work to support the Alberta Health Technologies Decision Process.
https://ift.tt/2FpbpSO
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Ετικέτες
Σάββατο 28 Απριλίου 2018
Fecal Transplantation for the Treatment of Clostridium difficile-Associated Disease or Ulcerative Colitis [Internet].
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Summary Insulinomas are rare neuroendocrine tumours that classically present with fasting hypoglycaemia. This case report discusses an un...
-
The online platform for Taylor & Francis Online content New for Canadian Journal of Remote Sen...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου